共 189 条
[1]
Um SB(2014)Spatial epidemiology of dry eye disease: findings from South Korea Int J Health Geogr 13 31-100
[2]
Kim NH(2012)Dry eye disease: an immune-mediated ocular surface disorder Arch Ophthalmol 130 90-342
[3]
Lee HK(2004)Antiinflammatory therapy for dry eye Am J Ophthalmol 137 337-949
[4]
Song JS(2012)Clinical treatment of dry eye using 0.03 % tacrolimus eye drops Cornea 31 945-52
[5]
Kim HC(2004)Comparison of autologous serum eye drops with conventional therapy in a randomised controlled crossover trial for ocular surface disease Br J Ophthalmol. 88 647-1252
[6]
Stevenson W(2011)Treatment of Sjogren’s syndrome-associated dry eye an evidence-based review Ophthalmology 118 1242-57
[7]
Chauhan SK(2004)A randomized, double-masked, placebo-controlled, multicenter comparison of loteprednol etabonate ophthalmic suspension, 0.5 %, and placebo for treatment of keratoconjunctivitis sicca in patients with delayed tear clearance Am J Ophthalmol 138 444-974
[8]
Dana R(2000)Efficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease: a dose-ranging, randomized trial. The Cyclosporin A Phase 2 Study Group Ophthalmology 107 967-639
[9]
Pflugfelder SC(2000)Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group Ophthalmology 107 631-1794
[10]
Moscovici BK(2005)Phase III safety evaluation of cyclosporine 0.1 % ophthalmic emulsion administered twice daily to dry eye disease patients for up to 3 years Ophthalmology 112 1790-1104